Zoghbi Huda Y Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$9.97M

Insider Activity of Zoghbi Huda Y

According to the SEC Form 4 filings, Zoghbi Huda Y, being in a position of

  1. director at Regeneron Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2438 shares for $1.92M,
    over all time since 2020-05-07, has bought 0 shares, and sold 17791 share for $11.89M.

Biography of Zoghbi Huda Y

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,919,8122100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleRegeneron Pharmaceuticals, Inc.
REGN
director
800
0.0008%
$800.00$640,000-0.83%
2026-02-19SaleRegeneron Pharmaceuticals, Inc.
REGN
director
1,638
0.0016%
$781.33$1.28M-4.02%
2024-01-02SaleRegeneron Pharmaceuticals, Inc.
REGN
director
1,117
0.001%
$900.00$1.01M+6.92%
2023-10-13SaleRegeneron Pharmaceuticals, Inc.
REGN
director
1,000
0.0009%
$850.00$850,000+15.02%
2022-03-16SaleRegeneron Pharmaceuticals, Inc.
REGN
2,000
0.0019%
$675.00$1.35M+4.48%
2021-09-14SaleRegeneron Pharmaceuticals, Inc.
REGN
director
998
0.0009%
$650.00$648,700-3.45%
2021-09-13SaleRegeneron Pharmaceuticals, Inc.
REGN
director
2
<0.0001%
$651.10$1,302-2.6%
2020-07-07SaleRegeneron Pharmaceuticals, Inc.
REGN
director
1,706
0.0016%
$650.00$1.11M-19.25%
2020-06-11SaleRegeneron Pharmaceuticals, Inc.
REGN
director
1,706
0.0016%
$625.00$1.07M-13.19%
2020-06-10SaleRegeneron Pharmaceuticals, Inc.
REGN
director
1,706
0.0016%
$610.24$1.04M-14.68%
2020-05-07SaleRegeneron Pharmaceuticals, Inc.
REGN
director
5,118
0.0047%
$566.52$2.9M-0.73%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.